3DUGGAL J,SINGH S,BARSANO C P,et al.Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism:pathophysiology and management[J].J Cardiometab Syndr,2007,2(3):198-206.
4FELDT-RASMUSSEN U.Treatment of hypothyroidism in elderly patients and in patients with cardiac disease[J].Thyroid,2007,17(7):619-624.
5Gomberg-Maitland M. Frishman WH.Thyroid hormone and cardiovaseular disease[J]. Am Heart J, 2008,145 ( 2 ) : 187-197.
6Bobadilla I, Franco M, Cruz D, et al. Hypothyroidism provides resistance to reperfusion injury following myoeardium isehemia[J]. Int J Bioehem Cell Biol, 2009,41 (4): 499-506.
7Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart[J]. Endocr Rev, 2005,26 ( 5 ) : 704-728.
8Beyer IW, Karmali R, DemeesterMirkine N, et al. Serum creatine kinase levels in overt and subclinical hypothyroidism[J]. Thyroid, 2008,18 ( 11 ): 1029- 1031.
9Mary KK. Applied therapeutics:the clinical use of drugs. America: Lippincott williams and wilkins: ninth, 2008.
10Tzankoff SP, Norris AH. Effect of muscle mass decrease on age related BMR changes. J APP1 Physiol, 1977,43 : 1001-1002.
